LuMind IDSC Foundation
Academic Hospitals & Non-Profit Organizations Disease FoundationBurlington, MA
OUR AMBITION: We hope to meaningfully improve health and independence in people with Down syndrome through cutting-edge science.
WHAT WE DO: LuMind RDS partners with industry and academic institutions to rapidly and successfully translate research into drugs and interventions. We have established a focused research agenda based on four Down syndrome research priority areas, including research targeting the root cause of Down syndrome as well as symptoms:
1. Prevent Alzheimer’s onset
2. Improve cognition
3. Develop gene therapies
4. Advance understanding
A HISTORY OF SUCCESS: Established in 2004, we have invested $17M to top academic institutions and biopharmaceutical companies leading to substantial concurrent funding from the NIH, industry and other sources. LuMind RDS-funded research has led to the discovery of 10 therapeutic targets, 2 Down syndrome-specific cognitive assessment scales, and 14 interventional and observational clinical trials in 1300 participants.
OUR TEAM: We have a highly dedicated Team including a large number of committed volunteers working on accelerating the translation of research for people with Down syndrome. Our CEO and Board of Directors have deep drug development expertise and a vast academic and industry network to draw upon. To join our mission in any capacity, do not hesitate to contact us on firstname.lastname@example.org .